Clinical Trials Logo

Clinical Trial Summary

The aim in this study is to determine whether there is a relationship between Thiol / Disulphide levels in primary infertile patients and comparing them with infertile patients and the control group. For this purpose, 41 women followed up with the diagnosis of primary infertility in Siirt Training and Research Hospital between November 2022 and January 2023 will be included in the study. The same number of (n:41) non-infertile control women will be included. Age, pregnancy history and medical history of both groups will be recorded. FSH, LH, E2, TSH, and prolactin levels taken routinely in these patients will be examined. Thiol/disulphide levels in the blood will be checked by taking whole blood from these patients. In the light of the information thus obtained, the investigator plan to determine whether there is a relationship between oxidant/antioxidant balance in primary infertile patients.


Clinical Trial Description

Reactive oxygen species (ROS) are products of normal cellular metabolism and consist of oxygen ions, free radicals and peroxides. Adding an electron to oxygen creates the superoxide anion radical, which can then be converted to a hydroxyl radical, peroxyl radical, or hydrogen peroxide. Free radicals try to participate in chemical reactions that free themselves of their unpaired electrons and result in oxidation. Natural antioxidants found in the body include catalase, glutathione peroxidase, superoxide dismutase and glutathione reductase, vitamins C and E, ferritin, and transferrin. Other lifestyle factors such as smoking, diet, illness, pollution, stress, alcohol, and allergies also contribute to increased levels of free radicals, suggesting that these factors have a negative impact on female fertility, potentially through the formation of excessive oxidative stress. Excessive accumulation of ROS can damage cells, proteins, DNA and lipids; therefore, ROS levels are regulated by antioxidant mechanisms in the organism. A shift in the direction of ROS in this balance is called oxidative stress (OS). ROS produced in the follicle have important roles in folliculogenesis and ovulation. Granulosa cells produce antioxidants to protect oocytes from the harmful effects of excess ROS. OS has been implicated as an etiopathogenetic factor in female infertility. The number of studies examining the role of OS in the etiopathogenesis of infertility has increased in recent years, and it has been suggested that increased OS and/or decreased antioxidant defense mechanisms may contribute to infertility-related conditions. One of the defense mechanisms against OS in humans is the thiol redox reaction. The thiol consists of a sulfhydryl group, and under OS conditions these functional groups form reversible disulfide bridges. These bonds bring about functional and structural changes in proteins. Disulfide bonds are reduced to thiol groups through antioxidant mechanisms, thereby providing thiol/disulfide homeostasis. Thus, disulfide bridges are thought to be a marker of OS, while thiols are suggested to be members of the antioxidant system. Only one side of this equilibrium has been measured by Ellman (1979), whereas in recent years both sides of the thiol/disulfide equilibrium can be measured by the Erel and Neselioğlu assay method, allowing a full assessment of the thiol/disulfide status. Dynamic thiol/disulfide homeostasis, a recently identified marker of OS, is thought to have critical roles in pathological processes in various vital processes such as folliculogenesis and ovulation. n the literature review, there are studies investigating the relationship between infertility and oxidant/antioxidants. However, measurements require measuring a large number of parameters and many separate biomarkers. The thiol/disulfide balance is beneficial in terms of showing the oxidant/antioxidant balance in total. It was not possible to measure this balance simultaneously on both sides in the method measuring the thiol/disulfide balance by Newman in 1979. In recent years, it has become possible to measure the serum Thiol/disulfide balance bilaterally with the automatic spectrophotometric method described by Erel and Neşelioğlu. This study aims to investigate whether there is a relationship by measuring the Total oxidant/antioxidant load with the Thiol/disulfide method in patients with unexplained infertility, to investigate the relationship between thiol/disulfide homeostasis and impaired ovulation and fertility, and to analyze the potential pathogenetic mechanism. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05628766
Study type Observational
Source Siirt University
Contact
Status Completed
Phase
Start date November 30, 2022
Completion date April 21, 2023

See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A